Compare Novo Nordisk A/S (NVO) vs Oscar Health Inc (OSCR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Oscar Health Inc — how do they compare? Novo Nordisk A/S trades at $49.32 (market cap $220.53B), while Oscar Health Inc trades at $30.77 (market cap $8.92B). The key difference: Novo Nordisk A/S is far larger — about 24.7× Oscar Health Inc's market cap, and Novo Nordisk A/S pays a 3.63% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.
| NVO | OSCR | |
|---|---|---|
Market Cap | $220.53B | $8.92B |
Sector | Health | Health |
52-Week High | $71.70 | $32.18 |
52-Week Low | $35.29 | $10.85 |
Enterprise Value | $239.49B | $4.55B |
Dividend Yield | 3.63% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Oscar Health Inc
Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.
Read more on OSCR →
